Target intelligence / Profile preview

Thermal ablation via focused ultrasound

Molecular classification
Other (Device/energy-based therapeutic technique; not a molecular family)
01

Overview

Thermal ablation via focused ultrasound (often delivered by high-intensity focused ultrasound, HIFU) is a non-invasive therapeutic procedure that uses focused acoustic energy to rapidly raise the temperature within a defined tissue volume, resulting in precise, localized destruction of tumor or targeted tissue through protein denaturation and coagulative necrosis. MRI or ultrasound guidance allows for millimeter-level targeting and real-time monitoring. This modality is FDA-cleared or approved for several indications, primarily in oncology and certain neurological disorders, and ongoing research explores combinatorial regimens with immuno-oncology drugs and techniques for blood-brain barrier disruption.

Other names
High-intensity focused ultrasound ablationHIFUMR-guided focused ultrasound ablationMRgFUS (Magnetic resonance-guided focused ultrasound)Focused ultrasound ablation
02

Mechanism of action

Localized thermal ablation (direct heating induces protein denaturation, cell lysis, and coagulative necrosis) Mechanical ablation (cavitation and tissue fractionation in some protocols) Potential immune modulation (secondary effect through antigen presentation after tumor cell kill)

03

Biological functions

Local tissue destructionCoagulative necrosis inductionTumor cell deathImmune activation (secondary, through tumor antigen release and inflammation in some settings)
04

Disease associations

Cancer (common for solid tumors, prostate, breast, bone metastases)Neurological disease (e.g., essential tremor, Parkinson’s disease)Benign tumorsChronic pain (via neurological ablation)
05

Safety considerations

Potential for unintended thermal damage to surrounding or adjacent tissuesPain or burns at focus areaRisk of collateral nerve damage, especially in brain or prostateRisk of incomplete ablation if targeting is imprecise or tissue characteristics are not uniform
06

Interacting drugs

None directly; however, some studies combine focused ultrasound with agents such as gemcitabine in cancer protocols
07

Biomarkers

Imaging biomarkers (MRI thermometry, lesion visualization)No canonical molecular biomarkers; procedure is guided and assessed by imaging

Beyond the preview

Go deeper on Thermal ablation via focused ultrasound.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thermal ablation via focused ultrasound.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call